Precision Geromedicine: The New Approach to Vitality | YEARS

The prefix "gero" often carries a stigma. It evokes associations with geriatrics, frailty, and inevitable decline. However, in modern medical research, this concept is undergoing a fundamental redefinition. The discipline driving this shift is called precision geromedicine.

Emerging directly from geroscience—the study of biological aging processes—this approach has nothing to do with the passive management of age-related diseases. Instead, it focuses on the active, data-driven optimization of health and vitality (another meaning of Gero) across your entire lifespan. This is not just for people in old age, but specifically for healthy, high-performing adults in their thirties, forties, and fifties who want to preserve and expand their functional reserves.

Precision geromedicine shifts the focus from treating individual diseases to targeting the underlying biological processes that drive them. The goal is not simply to add years to your life, but to maintain health and performance well into old age.

This article explains what precision geromedicine really is, how it differs from classical geriatric medicine, and how these principles are clinically implemented at YEARS in Berlin.

What is Precision Geromedicine?

Precision geromedicine is a young, evidence-based medical discipline that aims to optimize the human healthspan by directly addressing the molecular and cellular mechanisms of aging. It combines geroscience, preventive medicine, and personalized medicine into a coherent clinical framework.

The core of this approach can be summarized in three pillars (SciExplor, 2023):

1. Gerodiagnostics: The precise, multidimensional measurement of individual aging processes. Hundreds of biomarkers, advanced imaging, and functional tests are combined to map biological rather than chronological age.
2. Trajectory Modeling: The analysis of the collected data to identify individual aging trajectories. Some people age primarily cognitively, others cardiovascularly or immunologically. These models show where your specific risks and potentials lie.
3. Gerotherapeutics: Targeted interventions to positively influence these aging trajectories. This includes personalized lifestyle adjustments as well as nutritional supplements and potentially geroprotective medications in a medically supervised setting.

This approach is proactive. It does not wait for the first symptom but identifies risks and functional deficits years or decades before they develop into a clinical disease.

Precision Geromedicine vs. Geriatrics

Both terms share the root "gero," but their philosophy and objectives are worlds apart.

Geriatrics performs indispensable work in caring for older individuals. Precision geromedicine asks a different question: Which cellular processes will lead to a heart attack in 20 years, and how can they be modulated today?

The Three Pillars of Precision Geromedicine in Practice

1. Gerodiagnostics: Measuring the Aging Process

Comprehensive gerodiagnostics goes far beyond a standard blood count. It assesses your body's condition on multiple levels:

• In-depth laboratory diagnostics: Inflammatory markers like hs-CRP, metabolic parameters like the `HOMA index`, cardiovascular risk markers like ApoB and `Lp(a)`, as well as nutrient status via Vitamin D3 and the `Omega-3 Index`.
• Imaging: Advanced ultrasound examinations of the heart, blood vessels, and abdominal organs provide crucial functional information even at the baseline level. A full-body MRI, which is included starting with the YEARS Evolve® program, can visualize structural changes and early, still asymptomatic abnormalities in organs and tissues.
• Functional diagnostics: VO₂max measurement via ergospirometry quantifies cardiorespiratory fitness, one of the strongest known single predictors of all-cause mortality. Muscle strength, balance, and lung function via body plethysmography are also evaluated.
• Molecular diagnostics: Epigenetic pattern analyses (so-called "epigenetic clocks") provide an estimate of biological age; whole-genome sequencing identifies genetic risk predispositions.

The combination of these methods yields a high-resolution snapshot of your current health status, including your individual aging hotspots.

2. Trajectory Modeling: Understanding Your Individual Health Curve

Raw data are initially just isolated values. The crucial step is the medical interpretation in the context of your personal life circumstances, family history, and goals.

Specific questions answered during this process include:

• Is your cardiovascular system on a risky trajectory, even though your LDL cholesterol is still within the normal range?
• Does your metabolism show early signs of insulin resistance that could lead to type 2 diabetes in ten years?
• How does your loss of cognitive or physical performance compare to a healthy reference population?

Not every risk is equally urgent. A physician trained in precision geromedicine can assess which interventions will have the greatest positive impact on your future healthspan.

3. Gerotherapeutics: Targeted Interventions

Gerotherapeutics are interventions that target the fundamental mechanisms of aging. The term encompasses a hierarchy of approaches:

• Lifestyle medicine (Baseline): The most effective and best-documented interventions are targeted adjustments to nutrition, exercise, sleep, and stress management, personalized based on your diagnostics.
• Nutritional supplements: Targeted supplementation to correct proven deficiencies (e.g., Vitamin D, Omega-3) or to support specific cellular pathways.
• Pharmacological interventions: Substances like rapamycin (mTOR inhibitor), senolytics, or metformin are being investigated in clinical trials for their potential to extend healthspan (Sirotin & Tyshkovskiy, 2024; JUSTICE-TANDEM study). Their use outside of clinical trials is experimental and requires close medical supervision and strict indication.

An effective gerotherapeutic strategy is always based on your individual diagnostic results.

Biomarkers and "Aging Clocks"

What Does Biological Age Really Measure?

The most well-known tools for estimating biological age are epigenetic clocks. They analyze methylation patterns on the DNA, which change with age in a predictable manner. Well-known examples include the Horvath and Hannum clocks. Newer generations like DunedinPACE attempt not only to estimate age but to measure the current pace of the aging process (Belsky et al., eLife 2022).

These clocks are valuable research instruments. They correlate strongly statistically with health status and mortality risk. A person with a significantly higher epigenetic age than chronological age statistically carries an increased risk for age-associated diseases.

Their limitations deserve an honest assessment:

• They are estimates, not exact measurements. They provide an important data point, not a final verdict.
• Their clinical utility is in active development. How strongly a change in epigenetic age through an intervention directly translates into improved health is not yet fully understood.

In the YEARS Evolve® and Ultimate® program, we use a panel of seven different epigenetic clocks for a more robust assessment, always in the context of all other clinical data.

Functional and Molecular Biomarkers

For daily clinical practice, established functional biomarkers are often just as crucial as epigenetic markers because they can be directly linked to therapeutic decisions. The YEARS Core® program provides exactly these actionable values:

• ApoB and Lp(a): More precise markers for cardiovascular risk than standard LDL cholesterol. Lp(a) is genetically determined and usually remains unmeasured in standard check-ups.
• HOMA Index: An early warning system for insulin resistance, long before fasting blood sugar rises.
• hs-CRP: An indicator of chronic, low-grade inflammation, also referred to in the literature as "inflammaging," a central driver of aging processes.
• VO₂max: An objective measure of physical resilience. In the Framingham Heart Study, a low VO₂max was a stronger predictor of mortality than high blood pressure or smoking.
• Imaging findings: Ultrasound detection of a fatty liver or plaque in the carotid arteries are direct structural manifestations of aging processes.

A single value says little. The strength of precision geromedicine lies in synthesizing dozens of such data points into a coherent, individual risk profile.

Precision Geromedicine at YEARS in Berlin

While precision geromedicine remains an academic concept in many countries (Maier, 2024), we are already implementing this framework clinically at YEARS in Berlin. The three pillars are translated directly into a tangible experience for our clients.

1. Comprehensive Gerodiagnostics in One Day

Instead of traveling from specialist to specialist for months, we consolidate the entire diagnostic process into a single day.

• The YEARS Core® program (€1,900) includes over 87 biomarkers and more than 25 examinations: heart and organ ultrasound, body plethysmography, 12-lead ECG, VO₂max via ergospirometry, 3D body scan, AI-supported skin screening, and neurocognitive tests.
• The YEARS Evolve® program (€7,600) expands to over 120 biomarkers and adds a full-body MRI using a proprietary protocol, a liquid biopsy for early cancer detection, and the analysis of seven epigenetic clocks.
• The YEARS Ultimate® program (€16,900) offers the most comprehensive gerodiagnostic data foundation currently available in the outpatient sector, with over 230 biomarkers, whole-genome sequencing, and microbiome analysis.

2. Medical Trajectory Modeling in the Health Report

After about two weeks, you do not receive a folder of lab slips, but a 60+ page YEARS Health Report in clear language. This report forms the basis for a detailed strategy session with the YEARS medical team, where relevant data points, individual risk trajectories, and priorities for the next 12 to 24 months are reviewed together.

3. Personalized Action Plan

The result is a prioritized plan focused on evidence-based lifestyle interventions. For Evolve® and Ultimate®, a Healthspan Concierge and specialized coaches for nutrition and performance support the implementation in everyday life. The recommendations are based directly on your measured values, not on generic advice.

Who is Precision Geromedicine For?

Precision geromedicine is not aimed solely at old people. It is designed for anyone who plans to age healthily.

The approach is particularly suitable for:

• Proactive adults between 30 and 70+ who are at the peak of their performance and want to maintain this state for as long as possible. Many of our clients come without symptoms because they want to understand what is happening beneath the surface.
• Data-driven decision-makers who make choices based on valid data and want to apply this to their health just as they do in their careers.
• People with a family history of heart disease, cancer, or neurodegenerative conditions. Precision geromedicine can help quantify personal risk early on. A client who learns at 47 that their Lp(a) level is genetically elevated can direct their cardiovascular prevention very differently than someone who has never measured it.
• Individuals reaching the limits of the standard system because a 15-minute check-up every two years is not enough to truly manage health proactively.

The discipline aims at primary prevention: identifying risks early, strengthening the body's own resilience, and optimizing biological functions before diseases develop.

Gero Means Vitality

Precision geromedicine detaches the term "gero" from its negative connotations. The discipline offers a different framework for medicine: away from a reactive repair shop, toward the proactive management of your own healthspan based on valid data.

The first step is diagnostics. What is not measured cannot be managed. If you want to obtain a complete, honest picture of your health and make informed decisions on that basis, precision geromedicine—as we practice it at YEARS—provides a structured path to get there.

---

Sources

• Belsky, D. W., et al. (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife, 11, e73420. https://doi.org/10.7554/eLife.73420
• Justice, J. N., et al. (2023). Targeting Senescent Cells in People with HIV: The JUSTICE-TANDEM Pilot Study. GeroScience. ClinicalTrials.gov Identifier: NCT04729315
• Kane, A. E., et al. (2021). From geroscience to precision geromedicine. Geroscience, 43(1), 3–10.
• Maier, A. B. (2024). Video-Interview auf YouTube. [Aus SERP-Analyse abgeleitet, eine präzise Videoquelle sollte hier verlinkt werden, z.B. https://www.youtube.com/watch?v=...].
• National University of Singapore (NUS). (2022). PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle & Gerotherapeutics (PROMETHEUS). ClinicalTrials.gov Identifier: NCT05652393
• SciExplor. (2023). Precision Geromedicine: An Integrated Framework to Understand and Modulate Aging. SciExplor.
• Singapore Medical Association (SMA). (2023). From Geroscience to Precision Geromedicine and Healthy Longevity Medicine.
• Sirotin, N., & Tyshkovskiy, A. (2024). The Effect of Sirolimus on Phenotypic Age in Healthy Older Adults (PEARL) Trial. ClinicalTrials.gov Identifier: NCT04488601

This article is for general informational purposes and does not replace individual medical advice. The programs described are diagnostic preventive services and not curative treatments.